[go: up one dir, main page]

AU2002229440A1 - Human acid phosphatase gene - Google Patents

Human acid phosphatase gene

Info

Publication number
AU2002229440A1
AU2002229440A1 AU2002229440A AU2002229440A AU2002229440A1 AU 2002229440 A1 AU2002229440 A1 AU 2002229440A1 AU 2002229440 A AU2002229440 A AU 2002229440A AU 2002229440 A AU2002229440 A AU 2002229440A AU 2002229440 A1 AU2002229440 A1 AU 2002229440A1
Authority
AU
Australia
Prior art keywords
acid phosphatase
phosphatase gene
human acid
human
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002229440A
Inventor
Eleftherios P. Diamandis
Maria Diamandis
George Yousef
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mt Sinai Hospital
Original Assignee
Mt Sinai Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mt Sinai Hospital filed Critical Mt Sinai Hospital
Publication of AU2002229440A1 publication Critical patent/AU2002229440A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2002229440A 2001-02-02 2002-02-01 Human acid phosphatase gene Abandoned AU2002229440A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26625301P 2001-02-02 2001-02-02
US60/266,253 2001-02-02
PCT/CA2002/000105 WO2002063013A2 (en) 2001-02-02 2002-02-01 Human acid phosphatase gene

Publications (1)

Publication Number Publication Date
AU2002229440A1 true AU2002229440A1 (en) 2002-08-19

Family

ID=23013809

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002229440A Abandoned AU2002229440A1 (en) 2001-02-02 2002-02-01 Human acid phosphatase gene

Country Status (2)

Country Link
AU (1) AU2002229440A1 (en)
WO (1) WO2002063013A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20041453A0 (en) 2004-11-11 2004-11-11 Pirkko Vihko Knockout Animals
FI20075466A0 (en) * 2007-06-19 2007-06-19 Chempath Oy Transmembrane acid phosphatase in the prostate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436703B1 (en) * 2000-03-31 2002-08-20 Hyseq, Inc. Nucleic acids and polypeptides
WO2001079454A1 (en) * 2000-04-13 2001-10-25 Smithkline Beecham Corporation Novel compounds
WO2002010363A2 (en) * 2000-07-28 2002-02-07 Incyte Genomics, Inc. Protein phosphatases

Also Published As

Publication number Publication date
WO2002063013A2 (en) 2002-08-15
WO2002063013A3 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
AU2002257076A1 (en) Nucleic acid shuffling
AU2002303243A1 (en) Imaging nucleic acid delivery
AU2002341964A1 (en) Medical connector
AU2002338529A1 (en) Biological pacemaker
AU2002332391A1 (en) Human secreted proteins
AU2002363329A1 (en) Pharmacogenomics-based system for clinical applications
AU2002329172A1 (en) Human secreted proteins
AU2002350942A1 (en) Imidazolidineacetic acid derivatives
AU2002323437A1 (en) Gene identification
AU2002366435A1 (en) Nucleic acid amplification
AU2002329931A1 (en) Salvianolic acid b
AU2002229440A1 (en) Human acid phosphatase gene
AU2002343043A1 (en) Processing nucleic acid
AU2002357506A1 (en) Acid-containing preparations
AU2002317763A1 (en) Human protein phosphatase 2c-like enzyme
AU2002329425A1 (en) Dna sequencer
AU2002328502A1 (en) Novel human bmcc1 gene
AU2002328863A1 (en) Oncosuppressive gene
AU2002318544A1 (en) Elk1 phosphorylation-associated gene
AU2002343924A1 (en) Hepnadc gene
HK1060579A (en) Oncosuppressive gene
AU2002337325A1 (en) Gene expression
HK1066829A (en) Regulated nucleic acid expression system
AUPR799601A0 (en) Sex specific gene
AU2002232173A1 (en) Novel gene tcif

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase